Global Amlodipine And Olmesartan Market Size By Product (5/20 mg Tablets, 10/20 mg Tablets), By Application (Hospital, Drug Stores), By Geographic Scope And Forecast

Amlodipine And Olmesartan Market Size And Forecast

Amlodipine And Olmesartan Market size was valued at USD 574.4 Million in 2022 and is projected to reach USD 873.4 Million by 2030, growing at a CAGR of 4.1% from 2023 to 2030.

The Global Amlodipine And Olmesartan Market have grown rapidly due to the increasing prevalence of chronic diseases such as high blood pressure, hypertension, heart attacks, and kidney problems, as well as the rise in healthcare spending by the governments. These factors will drive the market growth significantly. The Global Amlodipine And Olmesartan Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Amlodipine And Olmesartan Market Definition

Amlodipine and Olmesartan are drug combinations that can be used alone or in combination with other medications to treat high blood pressure, hypertension, heart attacks, and kidney problems. A combination of Amlodipine and Olmesartan targets different mechanisms of action and may be more effective at lowering blood pressure. They both work by relaxing blood vessels, allowing blood to flow more freely. Amlodipine works by blocking calcium channels. It influences calcium transport into the heart and blood vessels.

Amlodipine relaxes the blood vessels, increasing blood and oxygen supply to the heart while decreasing its workload. Olmesartan works as an angiotensin II receptor blocker (ARB). It works by preventing material in the body from contracting the blood vessels. As a result, Olmesartan relaxes blood vessels. This lowers blood pressure while increasing blood and oxygen supply to the heart. This medication is usually taken once daily by mouth, with or without food, as directed by a doctor.

The dosage is usually determined by the patient’s medical condition and response to treatment. To reduce the risk of side effects, the doctor may advise starting this medication at a low dose and gradually increasing it. If a person also takes cholesterol-lowering medications (bile acid-binding resins such as cholestyramine, colesevelam, or colestipol), they should take amlodipine/olmesartan at least 4 hours before any of these medications. If an immediate result is required, one should take this medicine on a regular basis.

Global Amlodipine And Olmesartan Market Overview

The Global Amlodipine And Olmesartan Market is expected to experience remarkable growth in the upcoming years owing to the factors the increasing prevalence of chronic diseases such as high blood pressure, hypertension, heart attacks, and kidney problems are driving the Global Amlodipine And Olmesartan Market growth. Chronic kidney disease affects approximately 14% of the world’s population, and studies show that diabetes and hypertension are the two major causes. The increased use of Amlodipine and Olmesartan in preterm labor to develop the baby’s lung capacity and to treat critically high blood pressure in pregnancy is also fueling the market growth.

Additionally, rising government healthcare spending is expected to drive market growth during the forecast period. Sedentary is a term that is frequently associated with today’s lifestyle. The demand for people to stay active has declined significantly due to the high-pressure work-life and air-conditioned work conditions of corporates. All of these factors contribute to lifestyle diseases such as diabetes, hypertension, and cardiovascular disease. While a lack of activity will increase the disease’s chances, a growing population that relies on smoking and alcohol to de-stress is expected to reduce the incidence of cardiovascular diseases.

All of the aforementioned conditions are treated with amlodipine and olmesartan. With the number of patients increasing, the Global Amlodipine And Olmesartan Market is expected to grow in the future. However, strict government regulations and side effects associated with Amlodipine and Olmesartan consumption, such as dizziness, headache, intense abdominal pain, and nausea, are expected to be major factors limiting market growth over the forecast period.

Global Amlodipine And Olmesartan MarketSegmentation Analysis

The Global Amlodipine And Olmesartan Market are segmented on the basis of Product, Application, And Geography.

Amlodipine And Olmesartan Market, By Product

• 5/20 mg Tablets• 10/20 mg Tablets• 5/40 mg Tablets• 10/40 mg Tablets

Based on Product, The market is bifurcated into 5/20 mg Tablets, 10/20 mg Tablets, 5/40 mg Tablets, and 10/40 mg Tablets. The 10/40 mg Tablets segment accounts for the highest revenue share of the Global Amlodipine And Olmesartan Market in 2020 and is expected to dominate the market over the forecast period owing to it being the most commonly prescribed dose of Amlodipine and Olmesartan treat various cardiovascular diseases.

Amlodipine And Olmesartan Market, By Application

• Hospital• Drug Stores

Based on Application, The market is bifurcated into Hospital and Drug Stores. The Drug Stores segment is expected to hold the largest revenue share of the Global Amlodipine And Olmesartan Market during the forecast period owing to the high availability of Amlodipine and Olmesartan medications at Drug Stores.

Amlodipine And Olmesartan Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Regional Analysis, The Global Amlodipine And Olmesartan Market are classified into North America, Europe, Asia Pacific, and the Rest of the world. Among the regional markets, North America accounts for the largest revenue share in the Global Amlodipine And Olmesartan Market in 2020 and is expected to retain its dominance throughout the forecast period. The revenue growth in the North American market is mainly attributed to rising hypertension and diabetic populations, as well as an extremely aware consumer base in this region. The Asia Pacific region is expected to grow in the coming years, as it is home to a notable proportion of the affected patient population.

Key Players

The “Global Amlodipine And Olmesartan Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Glenmark Pharmaceuticals, Teva, Torrent Pharmaceuticals, Daiichi Sankyo, Accord Healthcare, Macleods Pharmaceuticals, Alembic Pharmaceuticals, Aurobindo, Matrix Laboratories, and Ajanta Pharma. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In January 2022, Daiichi Sankyo Company, Limited and Daiichi Sankyo, Inc. (hereafter, Daiichi Sankyo) entered into a strategic agreement with Cosette Pharmaceuticals, Inc. under which Daiichi Sankyo has divested and Cosette has acquired the manufacturing, commercialization, and certain other rights in the United States for some of the products including AZOR (amlodipine/olmesartan medoxomil), BENICAR (olmesartan medoxomil), TRIBENZOR (olmesartan medoxomil/amlodipine/hydrochlorothiazide), etc.

• In November 2021, Central Drugs Standard Control Organization (CDSCO) granted Torrent Pharmaceuticals to manufacture and market the additional strength of fixed-dose combination drug Amlodipine 10mg plus Olmesartan Medoxomil USP 40mg Tablet.

• In July 2017, The United States Food and Drug Administration (US FDA) granted final approval to Glenmark Pharmaceuticals for Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, and 10 mg/40 mg, the generic version of Daiichi Sankyo, Inc.’s Azor Tablets, 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, and 10 mg/40 mg.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.